These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1692 related items for PubMed ID: 14696397

  • 1. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 2. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE.
    N Engl J Med; 1995 May 04; 332(18):1192-7. PubMed ID: 7700312
    [Abstract] [Full Text] [Related]

  • 3. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, Lafortune M, Pomier-Layrargues G.
    Am J Gastroenterol; 1999 May 04; 94(5):1361-5. PubMed ID: 10235219
    [Abstract] [Full Text] [Related]

  • 4. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M, Cholongitas E, Tibballs J, Burroughs A, Patch D.
    Eur J Gastroenterol Hepatol; 2006 Nov 04; 18(11):1143-50. PubMed ID: 17033432
    [Abstract] [Full Text] [Related]

  • 5. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, Planas R, Bosch J, Arroyo V, Rodés J.
    Gastroenterology; 2002 Dec 04; 123(6):1839-47. PubMed ID: 12454841
    [Abstract] [Full Text] [Related]

  • 6. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Dec 04; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 7. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G, Nevens F, Stockx L, Raat H, Wilms G, Fevery J.
    Ned Tijdschr Geneeskd; 1996 Dec 07; 140(49):2455-8. PubMed ID: 8999346
    [Abstract] [Full Text] [Related]

  • 8. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA, Hoffman AL, Friedman ML, Sher LS, Lopez RR, Van Allen R, Brown DH, Fraiman MH, Arnaout W, Vierling J, Makowka L.
    Am Surg; 1996 Oct 07; 62(10):835-9. PubMed ID: 8813166
    [Abstract] [Full Text] [Related]

  • 9. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F, Pantea L, Sniderman K.
    Hepatology; 2004 Jul 07; 40(1):55-64. PubMed ID: 15239086
    [Abstract] [Full Text] [Related]

  • 10. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
    Rössle M, Gerbes AL.
    Gut; 2010 Jul 07; 59(7):988-1000. PubMed ID: 20581246
    [Abstract] [Full Text] [Related]

  • 11. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F, Baez AL, Pandula R, Walser E, Lau DT.
    J Gastroenterol Hepatol; 2005 Mar 07; 20(3):474-81. PubMed ID: 15740494
    [Abstract] [Full Text] [Related]

  • 12. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S, Singh R, Yoselewitz M.
    J Vasc Interv Radiol; 2004 Dec 07; 15(12):1431-4. PubMed ID: 15590801
    [Abstract] [Full Text] [Related]

  • 13. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G, Benner KG, Saxon R, Barton RE, Rabkin J, Keller FS, Rosch J.
    Am J Gastroenterol; 1997 Sep 07; 92(9):1444-52. PubMed ID: 9317060
    [Abstract] [Full Text] [Related]

  • 14. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A, Gulberg V, Sauter G, Waggershauser T, Reiser M, Gerbes AL.
    Hepatogastroenterology; 1998 Sep 07; 45(24):2315-21. PubMed ID: 9951915
    [Abstract] [Full Text] [Related]

  • 15. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
    Abouljoud M, Yoshida A, Kim D, Jerius J, Arenas J, Raoufi M, Brown K, Moonka D.
    Transplant Proc; 2005 Mar 07; 37(2):1248-50. PubMed ID: 15848685
    [Abstract] [Full Text] [Related]

  • 16. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes AL.
    N Engl J Med; 2000 Jun 08; 342(23):1701-7. PubMed ID: 10841872
    [Abstract] [Full Text] [Related]

  • 17. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW, Sood A, Jacobson IM, Brown RS.
    Am J Gastroenterol; 2003 Nov 08; 98(11):2521-7. PubMed ID: 14638358
    [Abstract] [Full Text] [Related]

  • 18. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
    Wróblewski T, Rowiński O, Ziarkiewicz-Wróblewska B, Górnicka B, Albrecht J, Jones EA, Krawczyk M.
    Transplant Proc; 2006 Nov 08; 38(1):204-8. PubMed ID: 16504703
    [Abstract] [Full Text] [Related]

  • 19. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V, Rodrigues SG, Stirnimann G, Gottardi A, Bosch J, Berzigotti A.
    United European Gastroenterol J; 2020 Oct 08; 8(8):961-969. PubMed ID: 32588789
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.
    Chen L, Xiao T, Chen W, Long Q, Li R, Fang D, Wang R.
    Liver Int; 2009 Aug 08; 29(7):1101-9. PubMed ID: 19386025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.